Cargando…

Effect of Entecavir on the Intestinal Microflora in Patients with Chronic Hepatitis B: A Controlled Cross-Sectional and Longitudinal Real-World Study

INTRODUCTION: This study aimed to analyze the diversity of intestinal flora in patients with chronic hepatitis B (CHB) and investigate the effect of entecavir on the intestinal flora in these patients. METHODS: Thirty patients with CHB and 30 healthy controls were recruited from the Department of In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yu-Xia, He, Cheng-Zhi, Wang, Ying-Xin, Ai, Zi-Sheng, Liang, Ping, Yang, Chang-Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Healthcare 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7954982/ https://www.ncbi.nlm.nih.gov/pubmed/33111216 http://dx.doi.org/10.1007/s40121-020-00355-w

Ejemplares similares

Effect of Additional Clostridium butyricum on the Intestinal Flora of Chronic Hepatitis B Patients Treated with Entecavir
por: Lu, Yu-Xia, et al.
Publicado: (2021)

Efficacy of Real-world Entecavir Therapy in Treatment-naïve Chronic Hepatitis B Patients
por: Xie, Yan-Di, et al.
Publicado: (2017)

Corrigendum: Efficacy of Real world Entecavir Therapy in Treatment NaïveChronic Hepatitis B Patients
Publicado: (2017)

Comparable efficacy with entecavir monotherapy and tenofovir–entecavir combination in chronic hepatitis B patients
por: Baqai, Sumbella, et al.
Publicado: (2015)

Real-world single-center experience with entecavir and tenofovir disoproxil fumarate in treatment-naïve and experienced patients with chronic hepatitis B
por: Kim, Young Min, et al.
Publicado: (2018)

Tenofovir alafenamide versus entecavir for treating hepatitis B virus-related acute-on-chronic liver failure: real-world study
por: Peng, Wenting, et al.
Publicado: (2023)

The role of entecavir in the treatment of chronic hepatitis B
por: Dimou, Evangelini, et al.
Publicado: (2007)

Sequential therapy from entecavir to tenofovir alafenamide versus continuous entecavir monotherapy for patients with chronic hepatitis B
por: Itokawa, Norio, et al.
Publicado: (2020)

Real World Experience of Telbivudine Versus Entecavir in Patients with Chronic Hepatitis B, Including Long-Term Outcomes after Treatment Modification
por: Choi, Jong Won, et al.
Publicado: (2018)

Effects of cadmium exposure on intestinal microflora of Cipangopaludina cathayensis
por: Jiang, Jiao-yun, et al.
Publicado: (2022)

Safety and efficacy of entecavir for the treatment of chronic hepatitis B
por: Osborn, Melissa
Publicado: (2011)

Dupilumab in patients with chronic hepatitis B on concomitant entecavir
por: Ly, Karen, et al.
Publicado: (2019)

Performance evaluation of the HepB Typer-Entecavir kit for detection of entecavir resistance mutations in chronic hepatitis B
por: Ahn, Sang Hoon, et al.
Publicado: (2013)

240‐week entecavir maleate treatment in Chinese chronic hepatitis B predominantly genotype B or C
por: Xu, Jing‐Hang, et al.
Publicado: (2022)

Evolution of entecavir-resistant hepatitis B virus during entecavir and adefovir dipivoxil combination therapy
por: WANG, YANG, et al.
Publicado: (2016)

Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA
por: Kim, Dong Hyun, et al.
Publicado: (2017)

Entecavir for the treatment of real-life chronic hepatitis B patients: a study from Saudi Arabia
por: Al-Ashqar, Hamad Ibrahim, et al.
Publicado: (2013)

Entecavir downregulates interleukin-37 in patients with chronic active hepatitis B infection
por: Meng, Jiang-Ping, et al.
Publicado: (2020)

Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine
por: Cai, Shaohang, et al.
Publicado: (2017)

Association between Hepatic Steatosis and Entecavir Treatment Failure in Chinese Patients with Chronic Hepatitis B
por: Jin, Xi, et al.
Publicado: (2012)

An-Luo-Hua-Xian Pill Improves the Regression of Liver Fibrosis in Chronic Hepatitis B Patients Treated with Entecavir
por: Liu, Yi-Qi, et al.
Publicado: (2023)

Efficacy of Lamivudine or Entecavir on Acute Exacerbation of Chronic Hepatitis B
por: Kanda, Tatsuo, et al.
Publicado: (2011)

Entecavir and lamivudine therapy for severe acute chronic hepatitis B
por: LIU, CHANGHONG, et al.
Publicado: (2013)

Clinical utility of entecavir for chronic hepatitis B in Chinese patients
por: Wang, Jiyao
Publicado: (2013)

Effects of Aroclor 1254 on Intestinal Immunity, Metabolism, and Microflora in Zebrafish
por: Zhu, Di-Hua, et al.
Publicado: (2022)

Safety of entecavir antiviral therapyduring an accidental pregnancy in patients with chronic hepatitis B
por: Cao, Lihua, et al.
Publicado: (2023)

Irinotecan toxicity: genes or intestinal microflora?
por: Brandi, G, et al.
Publicado: (2009)

Impact of Deoxynivalenol on the Intestinal Microflora of Pigs
por: Waché, Yann J., et al.
Publicado: (2008)

The influence of the intestinal microflora to the efficacy of Rosuvastatin
por: Wang, Lijun, et al.
Publicado: (2018)

Icariin Metabolism by Human Intestinal Microflora
por: Wu, Hailong, et al.
Publicado: (2016)

Severe Acute Hepatitis B Treated With Entecavir.
por: De Socio, Giuseppe Vittorio Luigi, et al.
Publicado: (2011)

Efficacy of prolonged entecavir monotherapy in treatment-naïve chronic hepatitis B patients exhibiting a partial virologic response to entecavir
por: Choi, Han Na, et al.
Publicado: (2015)

Interactions between Intestinal Microflora/Probiotics and the Immune System
por: Zhang, Chen-xing, et al.
Publicado: (2019)

Clinical characteristics of patients with chronic hepatitis B who developed genotypic resistance to entecavir: Real-life experience
por: Kim, Hong Joo, et al.
Publicado: (2017)

Factors associated with persistent positive in HBV DNA level in patients with chronic Hepatitis B receiving entecavir treatment
por: Li, Jun, et al.
Publicado: (2023)

One hundred and ninety-two weeks treatment of entecavir maleate for Chinese chronic hepatitis B predominantly genotyped B or C
por: Xu, Jing-Hang, et al.
Publicado: (2022)

Obesity and hepatocellular carcinoma in patients receiving entecavir for chronic hepatitis B
por: Lee, Jaemin, et al.
Publicado: (2016)

Efficacy of Entecavir therapy in elderly patients with chronic hepatitis B infection
por: Tan, You-wen, et al.
Publicado: (2014)

Influence of hepatic steatosis on the outcomes of patients with chronic hepatitis B treated with entecavir and tenofovir
por: Kim, David Sooik, et al.
Publicado: (2019)

A five years study of antiviral effect of entecavir in Chinese chronic hepatitis B patients
por: Liu, Kehui, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_h3j2g2g6anl2r1dmcn9psmbgjs